University Industry Collaboration Guven Yalcintas, Ph.D. Vice President Technology Transfer Office...

transcript

University Industry CollaborationGuven Yalcintas, Ph.D.Vice PresidentTechnology Transfer OfficeThe Research Foundation of SUNYAlfred, NY-April 27, 2006

Peace and Prosperity Through Science and Collaboration www.crdf.org

Overview

• Define Technology Transfer• Funding Gap• Relationship

– Industry side

– University side

– Examples Big Company Collaboration Small Company Collaboration

• Ideal Collaboration

Technology Transfer Is…

Technology Transfer is…

Relationships

Contact Sports

Technology Transfer Is…

Intellectual

Property

Market

Development

Commercial

Development

SUNY Innovations

Unmet Needs

Licenses“Deals”

Spin-outsStart-ups

Funding Gap

University Relations from Industry Side

Annual R&D expenditure as % of sales income– The research-based pharmaceutical industry 19

– Chemicals in general 5

– Electronics 6-7 and

– Automobile manufacture 4-5

Highlights from 2005 Annual Report

Chartered in 1951Chartered in 1951– Sponsored ResearchSponsored Research

• 8,300 programs8,300 programs

• $735 million in FY ending 2005$735 million in FY ending 2005

• 60% government – 40% private60% government – 40% private

– Technology TransferTechnology Transfer• Five Offices – 31/64 campusesFive Offices – 31/64 campuses

– 245 new invention disclosures245 new invention disclosures– 193 patent applications filed 193 patent applications filed – 78 license and option agreements executed78 license and option agreements executed– 34 U.S. patents issued in fiscal 200534 U.S. patents issued in fiscal 2005

RF, Central Office

Example of Hoffman-La Roche

• In 1996/97 spent $1.7 billion on research and development

• Development 70%, ie mostly clinical testing of new therapeutic compounds.

• Research-Discovery 30% • Outside of the company 5-10% of the discovery

expenditure, • This proportion is growing sharply to about 25%.

In Addition They Support

• Large number of PhD students• Postdoctoral fellowships and • Collaboration with universities on specific research

where the university has particular expertise. • Global activity and not confined to Europe.

In a Smaller Scale

Armored Dynamics– SUNY Geneseo

• Software need

– CACT-SUNY• Surface science

– NYSTAR– Product-Body armor to save lives

Commercial Development We “kiss a lot of frogs”

Commercial Development Sometimes they are still frogs

Commercial Development Sometimes they turn into a prince

Ideal Collaboration

Direct Response to Industry's needs– R&D Agreement

• IP Clause– Technology Development

» In University by Faculty» In company by Company Scientists» Either Place by Collaboration

• Joint Ownership

• First Right to Negotiate

Big Company’s Need•The research currently being done was not as productive as it would need to be in the future to maintain current business success. •The target is for each top 10 pharmaceutical company to produce 3-5 new successful chemical entities each year (currently companies typically are achieving about 1): •This would require about 35-50 new projects to be initiated each year.

Big Picture• Such a growth in activity will require a sharp increase in skilled people, or

• in the productivity of those currently employed, or the out-sourcing of projects, and particularly a lot of new ideas.

• Ideas were an essential element in achieving success, they alone were not always sufficient;

• successful innovations did not always rapidly follow from dramatic discoveries; eg monoclonal antibodies.

Final Picture

To achieve all of this activity,

Industry and universities must understand each other better and work more closely and productively

together.

Create Collaboration

Out of the Box– IP2IPO– Kairos

• Raising capital

• Flotation in London Market in 2007

– Relation with other universities• Imperial College

• Sheffield University

Summary

• Analyze • Be creative• Be flexible

University Industry Collaboration Guven Yalcintas, Ph.D. Vice President Technology Transfer Office...

Documents